Navigation Links
XTL Biopharmaceuticals Announces Financial Results for the Year Ended December 31, 2007
Date:3/20/2008

VALLEY COTTAGE, N.Y., March 20 /PRNewswire-FirstCall/ -- XTL Biopharmaceuticals Ltd. (Nasdaq: XTLB; TASE: XTL), a biopharmaceutical company engaged in the acquisition and development of therapeutics for the treatment of unmet medical needs, particularly diabetic neuropathic pain and hepatitis C, today announced its financial results for the year ended December 31, 2007.

At December 31, 2007, the Company had cash, cash equivalents and short- term bank deposits of $13.0 million, compared to $25.2 million at December 31, 2006. The decrease of $12.2 million during the year ended December 31, 2007 was attributable primarily to the Company's $7.5 million initial upfront license payment made in connection with the in-licensing of Bicifadine, a serotonin and norepinephrine reuptake inhibitor for the treatment of diabetic neuropathic pain, in January 2007, operating expenditures associated with the Phase 2b clinical trial of Bicifadine, the development of the DOS hepatitis C pre-clinical program, and operating expenditures associated with the Company's legacy hepatitis C clinical programs that were terminated in 2007, offset by $8.8 million in net proceeds from the private placement that was completed in November 2007.

The loss for the year ended December 31, 2007 was $24.9 million, or $0.11 per ordinary share, compared to a loss of $15.1 million, or $0.08 per ordinary share, for the year ended December 31, 2006, representing an increase in net loss of $9.8 million. The increased loss was primarily attributable to the $7.5 million upfront license fee in connection with the in-licensing of Bicifadine and additional costs associated with the Bicifadine clinical program, offset by lower costs associated with the Company's legacy hepatit
'/>"/>

SOURCE XTL Biopharmaceuticals Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) to be Presented at the Upcoming American Society of Hematology Meeting in Atlanta, Georgia
2. Nabi Biopharmaceuticals Completes Sale of Nabi Biologics to Biotest AG
3. Nabi Biopharmaceuticals Announces Third Quarter 2007 Financial Results and Positive Vote from November 8, 2007 Special Stockholders Meeting
4. Presentation Time Correction: Keryx Biopharmaceuticals Presents at 12:00pm, ET Tomorrow (Oct. 3) at William Blair & Company Small-Cap Growth Stock Conference
5. Perrigo Company Announces Launch of Clobetasol Propionate Foam
6. Batesville Holdings Announces New Board of Directors in Preparation for March 31 Spin-Off from Hillenbrand Industries
7. ReBuilder Medical Technologies, Inc. Announces Revolutionary Electronic Zapper Said to Destroy Molluscum Contagiosum Pathogen
8. Lifeway Foods Announces Expanded Distribution and Growing Success of ProBugs(TM) Organic Kefir for Kids
9. Dreier LLP Announces Class Action Lawsuit Against Vertex Pharmaceuticals Incorporated (VRTX)
10. Blue Cross and Blue Shield of Illinois Announces Wellness Tools and Resources
11. Blue Cross and Blue Shield of Illinois Announces Campaign to Address Childhood Obesity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... October 31, 2014 Becker's Hospital ... list "100 Hospitals and Health Systems With Great ... list lead the nation in cardiovascular and thoracic ... research, and all have received recognition from reputable ... the fifth time Becker's Hospital Review has compiled ...
(Date:10/31/2014)... (PRWEB) October 31, 2014 TheHardwareCity.com is ... for winter. Many quality electric space heaters are available ... the superior Broan-Nutone Big Heat 1500w portable electric space ... newly available at TheHardwareCity.com, offers an energy efficient way ... cabin. The ceramic heating elements produce 1500 Watts, ensuring ...
(Date:10/31/2014)... PA (PRWEB) October 31, 2014 Fundraising support ... are greater gains than losses. At noon on Monday, November ... Memorial Hospital (SSMH), greater than 20 Susquehanna Health (SH) ... locks to raise awareness and funds for the new Cancer ... shave participants’ heads for this act of love and support ...
(Date:10/31/2014)... division is central to life. The last stage, when ... scientists since the dawn of cell biology in the ... notoriously difficult to study this final step, when the ... , The name given to this process by those ... the sense of a highly active and organized series ...
(Date:10/31/2014)... October 31, 2014 Springboard Biodiesel, ... its small scale BioPro™ biodiesel processors, announced on ... further improve the performance and efficiency of small-scale ... GL95/MC12/BD380 trio will recover more than 99% ... with the glycerin by-product produced while making biodiesel. ...
Breaking Medicine News(10 mins):Health News:Becker's Hospital Review Names 100 Hospitals, Health Systems With Great Heart Programs 2Health News:Becker's Hospital Review Names 100 Hospitals, Health Systems With Great Heart Programs 3Health News:Becker's Hospital Review Names 100 Hospitals, Health Systems With Great Heart Programs 4Health News:Big Heat 1500w Electric Space Heater Now Available at TheHardwareCity.com 2Health News:Susquehanna Health Soldiers + Sailors Memorial Hospital Razing Heads to Fight Cancer 2Health News:Cell division, minus the cells 2Health News:Cell division, minus the cells 3Health News:Springboard Biodiesel Announces Release of New and Unique Methanol Recovery and Glycerin Treatment Equipment 2Health News:Springboard Biodiesel Announces Release of New and Unique Methanol Recovery and Glycerin Treatment Equipment 3
... COLUMBUS, Ohio -- An Ohio State University mathematician and his ... cells and abnormal cells, such as cancer cells, based on ... creating mathematical equations that describe the shape and motion of ... is in its early stages, it represents an entirely new ...
... TUESDAY, Jan. 25 (HealthDay News) -- Elderly patients with ... emergency department often do not comprehend why they are ... or nurses, a new study finds. U.S. researchers ... an emergency department and found that those with cognitive ...
... joined state, community and university partners on Jan. 25 ... health. The grant project will serve more than 1,200 ... cognitive and behavioral development services. Project LAUNCH ... serve children ages birth to 8 years old and ...
... , TUESDAY, Jan. 25 (HealthDay News) -- Epilepsy was the ... Frederic Chopin, according to a new study. Researchers reached ... the musician,s own descriptions of his hallucinations -- including his ... accounts of his life written by pupils and friends such ...
... , TUESDAY, Jan. 25 (HealthDay News) -- Following a series ... Administration is asking an expert panel to vote Tuesday on ... Over the past five years, there have been 68 recalls ... in cardiac arrest in hopes of getting the heart to ...
... ultrasound investigation and a blood test to measure the level ... future heart failure following acute coronary syndromes. This is the ... Sweden. Acute coronary syndromes, such as myocardial infarction and ... medical care and death in Sweden for both women and ...
Cached Medicine News:Health News:Researchers use cell 'profiling' to detect abnormalities -- including cancer 2Health News:Researchers use cell 'profiling' to detect abnormalities -- including cancer 3Health News:Elderly With Dementia, Delirium Confused by ER Visits: Study 2Health News:Federal grant helps LAUNCH improvements in children's health 2Health News:FDA Looking for Tougher Standards for External Defibrillators 2Health News:Ultrasound and a blood test can increase survival after myocardial infarction 2
(Date:10/31/2014)... 2014 Imago BioSciences, Inc., a biotech ... million Series A financing led by Clarus Ventures ... team of accomplished investment and operating professionals dedicated ... round include Frazier Healthcare, Amgen Ventures, and Merck ... and Frazier Healthcare will join the company,s board ...
(Date:10/31/2014)... , October 31, 2014 Investor-Edge ... (NASDAQ: NSPH ), Isis Pharmaceuticals Inc. (NASDAQ: ... HALO ), ACADIA Pharmaceuticals Inc. (NASDAQ: ... research on these five companies can be accessed at: ... 2014, the NASDAQ Composite ended at 4,566.14, up 0.37%, ...
(Date:10/31/2014)... 31, 2014  Encision Inc. (OTCQB:ECIA), a medical device ... electrosurgical burns in minimally invasive surgery, today announced financial ... 30, 2014. The Company posted quarterly net ... of $414 thousand, or $(0.04) per share. These results ... net loss of $50 thousand, or $(0.01) per share, ...
Breaking Medicine Technology:Imago BioSciences Announces $26.5 Million Financing Led by Clarus Ventures 2Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 2Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 3Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 4Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 5Encision Reports Second Quarter Fiscal Year 2015 Results 2Encision Reports Second Quarter Fiscal Year 2015 Results 3Encision Reports Second Quarter Fiscal Year 2015 Results 4Encision Reports Second Quarter Fiscal Year 2015 Results 5
... for spine tumorsLAS VEGAS, Feb. 22 For orthopaedic researcher ... a personal as well as a professional mission. Her cousin ... remembers the incredible pain her cousin experienced when the cancer ... Keyak and her colleagues at the University of California, ...
... Health Secretary Everette James today ... million will be awarded from Pennsylvania,s share of ... focus on specific research priorities established and reviewed ... chaired by Secretary James. The priorities for 2008-09 ...
Cached Medicine Technology:Breast Cancer Patients May Have a New Treatment Option When Cancer Spreads 2Breast Cancer Patients May Have a New Treatment Option When Cancer Spreads 3Rendell Administration Announces Health Research Grants From Tobacco Settlement Funds 2Rendell Administration Announces Health Research Grants From Tobacco Settlement Funds 3Rendell Administration Announces Health Research Grants From Tobacco Settlement Funds 4
... Aaron manufactures two groups of flexible ... sterile and non-sterile in three different sizes ... flexible shaft portion of the light). These ... additional light is needed., ,The second ...
These units, though small, still offer sufficient output to ensure current is fully adjustable from 0 to 70 mA. Instruction manual, ball electrodes, battery and leads with alligator clips are include...
... groups of flexible lighting products. The first ... three different sizes 5", 10", and 15" ... the light). These lights are for use ... ,The second group of flexible lights ...
These units, though small, still offer sufficient output to ensure current is fully adjustable from 0 to 70 mA. Instruction manual, ball electrodes, battery and leads with alligator clips are include...
Medicine Products: